The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications.
The Guidant Flextend lead is a steroid-eluting, transvenous pace/sense lead with an extendable/retractable active-fixation helix. The extendable/retractable helix design offers various lead placement
The Vitatron Impulse II lead series are silicon rubber endocardial leads specifically designed to extend the longevity of the pacemaker system by providing energy efficient pacing. The high impedance
The RZ is a small lead body profile implantable unipolar tined permanent pacing lead for stimulation of either the atrium (J model) or the ventricle (straight model).
Medicine Products:(Date:12/3/2008)...ass., Dec. 3 The Belmont(R) Rapid ...bat Support Hospitals to treat wounded,soldiers, ...ed with helping to,save the life of an Omaha, NE ...e times during a traffic stop. One of the bullets,...rupturing a major artery. , "Injury to this...
(Date:12/3/2008)...n,t respond at first not helped by maintenance tre...3 (HealthDay News) -- Maintenance therapy using lo...vanced chronic hepatitis C who haven,t responded t...ests. , The study also showed a surprising heal... course of four years. , "This course of treatm...
(Date:12/3/2008)... Cellastim, an animal-free recombinan...tperform animal and human derived serum in CHO cel..., CO (PRWEB) December 3, 2008 -- Cellastim has pro...lbumin in CHO media and can improve both the growt...ss a variety of chemically defined media. , , ,Stu...
(Date:12/3/2008)....J., Dec. 3 The followi..., New Jersey Hospital Association: , , "Sta...ospitals will share funding from the state,s $44 m...me news for those facilities, but the more soberin...hospitals have been turned away. While a worthy ef...
Breaking Medicine News(10 mins):Health News:Belmont(R) Rapid Infuser Helps Save Officer's Life 2Health News:Hepatitis C Therapy Useless for Some 2Health News:InVitria's Cellastim Delivers Superior Results in CHO Cell Culture 2(Date:11/28/2008)... GÿRLITZ, Germany, November 28 ...obal leadership in specialized HIV monitoring and,... and emerging countries. In,the year 2008, 2.5 mi...portable, robust and highly affordable "CyFlow" sy...le living with HIV/AIDS. Due to introduction of th...
(Date:11/27/2008)...ew study finds the majority of acute lymphoblastic...present at the time of diagnosis , , MEMPHI...tists at St. Jude Children,s Research Hospital hav...ncer cells of children with acute lymphoblastic le...s a pathway to designing treatments for ALL relaps...
(Date:11/26/2008)...ncreased information density, automation and intel...ncy in ultrasound to an all new level , , C...iemens Healthcare ( www.siemens.com/healthcare ...t Volume Scanner (ABVS)(1), the world,s first mul... at the 94th Scientific Assembly and Annual Meetin...
(Date:11/25/2008)...ymptom awareness can improve recovery , , A...ry are available on the Mayo Clinic News Blog. Ple... , , ROCHESTER, Minn., Nov. 25 /PRNewswir...ity of stroke patients don,t think they,re having ...ment until their condition worsens. The findings a...
Breaking Medicine Technology:German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Green potato health risk can be eliminated by cutting away affected area 4202 1Dataline Announces Participation in Operation Golden Phoenix 24399 1Dataline Announces Participation in Operation Golden Phoenix 24399 2Dataline Announces Participation in Operation Golden Phoenix 24399 3Aethon Inc Names New Chief Financial Officer 24396 1Aethon Inc Names New Chief Financial Officer 24396 2CVS pharmacy Raises Record breaking 244 4 Million for ALS Research Through Annual ALS Fundraising Campaign 24393 1CVS pharmacy Raises Record breaking 244 4 Million for ALS Research Through Annual ALS Fundraising Campaign 24393 2...al utilization management,programs, ST. PAUL, Minn...,manager Prime Therapeutics (Prime) today announce...attera(R) (atomoxetine) for treating,attention def...e,study found that children who start on Strattera...y than children who started on,stimulants. Due to ...
...PRNewswire-FirstCall/ --,Telik, Inc. announced tha... 2 trial of the triplet combination of TELCYTA(R),...axel will be,presented at the 98th annual meeting ...ACR) in Los Angeles. Preclinical studies of,cellul...cell growth,inhibition with TELCYTA in combination...
Other Medicine Technology:Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 2Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 3Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3